"They have really endless resources": Big Pharma spending $263M to keep drug prices high

Lowering prescription drug prices is among the Biden administration's most urgent priorities. But the drug industry is spending big to keep that from happening. 

A new compromise on Capitol Hill would offer some relief from high prices by gradually allowing Medicare to negotiate drug prices similar to private insurers for the first time, while capping out of pocket costs at $2,000 and setting limits on the cost of insulin. 

"This is the time to get real relief to senior citizens who are getting mugged at the pharmacy counter," Democratic Senator Ron Wyden said.